Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | NT5E | P21589 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8509316 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL2636631 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL15263324 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL2010790 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL5182595 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL240028 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL1994115 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL9393256 | 1.00 | HIF1A (0.43) | HIF1AADORA2AADORA2BLMNANT5E | |
| Water SCHEMBL5144372 | 0.99 | HIF1A (0.42) | HIF1AADORA2AADORA2BLMNANT5E | |
| SCHEMBL7643809 | 0.90 | PYGL (0.38) | HIF1AADORA2AADORA2BLMNANT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111724866-A | Automated prediction of biological response of compounds based on chemical information | 塔塔咨询服务有限公司 | 2020-09-29 | — | — | CN | disclosed |
| EP-2109448-B1 | Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin | ENZON PHARMACEUTICALS INC (US) | 2013-09-11 | — | — | EP | disclosed |
| EP-2120966-A2 | POLYMERIC SHORT INTERFERING RNA CONJUGATES | Enzon Pharmaceuticals, Inc. (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008070477-A9 | POLYMERIC SHORT INTERFERING RNA CONJUGATES | ENZON PHARMACEUTICALS INC (US) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008070477-A2 | POLYMERIC SHORT INTERFERING RNA CONJUGATES | ENZON PHARMACEUTICALS, INC. (US) | 2008-06-12 | — | — | WO | disclosed |
| EP-1261350-B1 | METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-BETA-D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE | SOUTHERN RES INST (US) | 2006-07-12 | — | — | EP | disclosed |
| EP-1261350-A4 | METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-$g(b)-D-ARABINOFURANOSYL)- i 9H /i -PURIN-6-AMINE | SOUTHERN RES INST (US) | 2003-04-16 | — | — | EP | disclosed |
| EP-1261350-A1 | METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-$g(b)-D-ARABINOFURANOSYL)- i 9H /i -PURIN-6-AMINE | Southern Research Institute (US) | 2002-12-04 | — | — | EP | disclosed |
| EP-1248791-A1 | ANTISENSE MODULATION OF CASPASE 3 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-10-16 | — | — | EP | disclosed |
| EP-1137764-A1 | NEW MEDICAL USE OF GENE AND VECTOR ENCODING A MULTISUBSTRATE DEOXYRIBONUCLEOSIDASE | Biovici (CH) | 2001-10-04 | — | — | EP | disclosed |
| WO-2001060383-A1 | METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-β-D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE | SOUTHERN RESEARCH INSTITUTE (US) | 2001-08-23 | — | — | WO | disclosed |
| WO-2001053310-A1 | ANTISENSE MODULATION OF CASPASE 3 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2001-07-26 | — | — | WO | disclosed |
| WO-2000036099-A1 | NEW MEDICAL USE OF GENE AND VECTOR ENCODING A MULTISUBSTRATE DEOXYRIBONUCLEOSIDASE | BIOVICI (CH) | 2000-06-22 | — | — | WO | disclosed |
| EP-0460045-A1 | NUCLEOSIDE ANALOGUES | UNIVERSITY COLLEGE LONDON (GB) | 1991-12-11 | — | — | EP | disclosed |
| WO-1990010012-A1 | NUCLEOSIDE ANALOGUES | UNIVERSITY COLLEGE LONDON (GB) | 1990-09-07 | — | — | WO | disclosed |
| EP-0156524-B1 | 2'-CHLOROPENTOSTATIN, A PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUND AND A NOVEL MICROORGANISM FOR PRODUCING THE COMPOUND | WARNER-LAMBERT COMPANY (US) | 1988-05-11 | — | — | EP | disclosed |
| EP-0015584-A2 | Nucleotides, methods for their preparation and medicaments | Gauri, Kailash Kumar, Dr. Prof. (DE) | 1980-09-17 | — | — | EP | disclosed |